Fri, May 08, 2026 | Updated 07.08AM IST
Weather
author

Divya Rajagopal

Divya Rajagopal is an Assistant Editor with The Economic Times newspaper based out of Mumbai, India. She writes on intersection of medical science and business.

Articles By Author

Healthcare's dilemma: Balancing public needs with business sense
Healthcare's dilemma: Balancing public needs with business sense
Govt now plans to put a price cap on non-essential drugs
Govt now plans to put a price cap on non-essential drugs
NPPA to look into diabetes drug price-fixing allegations
NPPA to look into diabetes drug price-fixing allegations
Sun Pharma resets goals, to focus on quality
Sun Pharma resets goals, to focus on quality
Demonetisation: People stock up on medicines to get rid of old notes
Demonetisation: People stock up on medicines to get rid of old notes
Piramal targets Rs 1,000 crore revenue in OTC business on back of buyouts
Piramal targets Rs 1,000 crore revenue in OTC business on back of buyouts
Biocon founder Kiran Mazumdar-Shaw backs two cancer startups
Biocon founder Kiran Mazumdar-Shaw backs two cancer startups
Phaneesh Murthy’s e-pharmacy Zigy may shut shop soon: Sources
Phaneesh Murthy’s e-pharmacy Zigy may shut shop soon: Sources
Meet four Indian startups fighting cancer
Meet four Indian startups fighting cancer
Drug prices to rise slightly on removal of duty relief
Drug prices to rise slightly on removal of duty relief
What's adding to woes of online pharmacy startups
What's adding to woes of online pharmacy startups
18 top Ranbaxy executives including Indrajit Banerjee, Yugal Sikri, get marching orders as part of integration plan with Sun Phama
18 top Ranbaxy executives including Indrajit Banerjee, Yugal Sikri, get marching orders as part of integration plan with Sun Phama
Gelatine makers cowed by beef ban
Gelatine makers cowed by beef ban
Twitter, Facebook need to play bigger role to check online abuse
Twitter, Facebook need to play bigger role to check online abuse
Pharma companies on a talent hunt to fill skills gap
Pharma companies on a talent hunt to fill skills gap
Don't wear a condom, wear values to fight AIDS: Harsh Vardhan
Don't wear a condom, wear values to fight AIDS: Harsh Vardhan
GSK CEO backs India’s pharma policy, cautious on acquisitions
GSK CEO backs India’s pharma policy, cautious on acquisitions
Telecom companies seek to increase mobile call rates by 10p/minute
Telecom companies seek to increase mobile call rates by 10p/minute
Women bloggers offer tips on work-life balance
Women bloggers offer tips on work-life balance
Debt-ridden Elder Pharmaceuticals up for sale
Debt-ridden Elder Pharmaceuticals up for sale
Dinesh Thakur: Meet the man who won Rs 244 crore for blowing the whistle against Ranbaxy
Dinesh Thakur: Meet the man who won Rs 244 crore for blowing the whistle against Ranbaxy
Lobby fears norms violation in Cipla's biosimilar drug
Lobby fears norms violation in Cipla's biosimilar drug
Only 3% of patents filed by MNC pharma firms under dispute: Study
Only 3% of patents filed by MNC pharma firms under dispute: Study
EU, Australia, Canada may follow India’s Patent Law
EU, Australia, Canada may follow India’s Patent Law
ICICI, HDFC Banks get strict on money laundering; offer immunity to staff who exposes wrongdoings
ICICI, HDFC Banks get strict on money laundering; offer immunity to staff who exposes wrongdoings
As economy fails to perk up, sex stimulation products grow fastest in pharma sector
As economy fails to perk up, sex stimulation products grow fastest in pharma sector
Pharma sector sales growth slump in December quarter
Pharma sector sales growth slump in December quarter
Cipla set to buy 51% of S Africa's Cipla Medpro for about $220 million
Cipla set to buy 51% of S Africa's Cipla Medpro for about $220 million
Drug pricing formula: Lawyers differ with Supreme Court
Drug pricing formula: Lawyers differ with Supreme Court
GE capital picks up 7.69% in Biocon's Syngene for Rs 125 crore
GE capital picks up 7.69% in Biocon's Syngene for Rs 125 crore
Load More Stories